1-[(S)-2-(3-Cyclohexyl-propionylamino)-3-methyl-butyryl]-piperidine-2-carboxylic acid ((S)-1-{(S)-2-[(1S,2R)-1-((S)-1-carbamoyl-3-methyl-butylcarbamoyl)-2-hydroxy-propylcarbamoyl]-pyrrolidine-1-carbonyl}-pentyl)-amide

ID: ALA2373021

Chembl Id: CHEMBL2373021

PubChem CID: 73347233

Max Phase: Preclinical

Molecular Formula: C41H71N7O8

Molecular Weight: 790.06

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCC[C@H](NC(=O)[C@@H]1CCCCN1C(=O)[C@@H](NC(=O)CCC1CCCCC1)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)[C@@H](C)O

Standard InChI:  InChI=1S/C41H71N7O8/c1-7-8-17-29(40(55)47-23-14-19-32(47)38(53)46-35(27(6)49)39(54)44-30(36(42)51)24-25(2)3)43-37(52)31-18-12-13-22-48(31)41(56)34(26(4)5)45-33(50)21-20-28-15-10-9-11-16-28/h25-32,34-35,49H,7-24H2,1-6H3,(H2,42,51)(H,43,52)(H,44,54)(H,45,50)(H,46,53)/t27-,29+,30+,31+,32+,34+,35+/m1/s1

Standard InChI Key:  JXMAVBNVCNTIDU-KNOMIANTSA-N

Alternative Forms

Associated Targets(Human)

TNFRSF10A Tchem TRAIL receptor-1 (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 790.06Molecular Weight (Monoisotopic): 789.5364AlogP: 2.42#Rotatable Bonds: 20
Polar Surface Area: 220.34Molecular Species: NEUTRALHBA: 8HBD: 6
#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.78CX Basic pKa: CX LogP: 2.41CX LogD: 2.41
Aromatic Rings: Heavy Atoms: 56QED Weighted: 0.11Np Likeness Score: -0.11

References

1. Hanson GJ, Vuletich JL, Bedell LJ, Bono CP, Howard SC, Welply JK, Woulfe SL, Zacheis ML.  (1996)  Design of MHC class II (DR4) ligands using conformationally restricted imino acids at p3 and p5,  (16): [10.1016/0960-894X(96)00348-4]

Source